Trial Profile
A Multi-center Randomized Placebo Controlled Trial Evaluating the Efficacy of JALYN in Improving Symptoms in Men Diagnosed With Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 03 Sep 2015
Price :
$35
*
At a glance
- Drugs Dutasteride/tamsulosin (Primary)
- Indications Benign prostatic hyperplasia; Prostatitis
- Focus Therapeutic Use
- 05 Nov 2013 Additional lead trial centre deleted as reported by ClinicalTrials.gov record.
- 26 Apr 2013 New trial record